Literature DB >> 21851932

Imaging features, follow-up, and management of incidentally detected renal lesions.

A J Bradley1, Y Y Lim, F M Singh.   

Abstract

Incidental renal masses are common findings on cross-sectional imaging. Most will be readily identified as simple cysts, but with an inexorable rise in abdominal imaging, [particularly computed tomography (CT)], coupled with a rise in the incidence of renal cancer, the likelihood of detecting a malignant mass is increasing. This review informs the radiologist which lesions can be safely ignored, which will require further imaging for accurate categorization, and which require referral for consideration of treatment. For the small proportion of lesions that are indeterminate, careful attention to imaging technique, and the use of unenhanced and contrast-enhanced CT or magnetic resonance imaging (MRI) in all but a few specific instances will accurately characterize such lesions. The figures have been chosen to illustrate specific imaging features of common renal lesions. Management options for malignant, or presumed malignant, renal masses include active surveillance, percutaneous ablation, laparoscopic or open, partial or total nephrectomy. Biopsy has a role in determining the nature of masses that remain indeterminate on cross-sectional imaging, prior to definitive treatment. Common pitfalls in assessing incidental renal lesions are emphasized; some of these are due to sub-optimal imaging techniques and others to errors in interpretation. 2011 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21851932     DOI: 10.1016/j.crad.2011.07.044

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  11 in total

Review 1.  Magnetic Resonance Imaging and the Use in Small Renal Masses.

Authors:  M Vedanayagam; B Bhattacharya; S Sriprasad
Journal:  Indian J Surg Oncol       Date:  2016-12-05

Review 2.  The role of imaging in the active surveillance of small renal masses.

Authors:  P G K Wagstaff; P J Zondervan; J J M C H de la Rosette; M P Laguna
Journal:  Curr Urol Rep       Date:  2014-03       Impact factor: 3.092

3.  Role of MRI in indeterminate renal mass: diagnostic accuracy and impact on clinical decision making.

Authors:  Taekmin Kwon; In Gab Jeong; Sangjun Yoo; JungBok Lee; Sungwoo Hong; Dalsan You; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  Int Urol Nephrol       Date:  2015-02-14       Impact factor: 2.370

4.  Common pitfalls in renal mass evaluation: a practical guide.

Authors:  Layra Ribeiro de Sousa Leão; Thais Caldara Mussi; Fernando Ide Yamauchi; Ronaldo Hueb Baroni
Journal:  Radiol Bras       Date:  2019 Jul-Aug

Review 5.  The Role of DNA Methylation in Renal Cell Carcinoma.

Authors:  Brittany N Lasseigne; James D Brooks
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

Review 6.  pH sensing and regulation in cancer.

Authors:  Mehdi Damaghi; Jonathan W Wojtkowiak; Robert J Gillies
Journal:  Front Physiol       Date:  2013-12-17       Impact factor: 4.566

7.  Clinical utility of gray scale renal ultrasound in acute kidney injury.

Authors:  Amber Podoll; Carl Walther; Kevin Finkel
Journal:  BMC Nephrol       Date:  2013-09-08       Impact factor: 2.388

8.  Improving patient notification of solid abdominal viscera incidental findings with a standardized protocol.

Authors:  Courtney E Collins; Nicole Cherng; Theodore McDade; Babak Movahedi; Timothy A Emhoff; Giles F Whalen; Jennifer LaFemina; Jon D Dorfman
Journal:  J Trauma Manag Outcomes       Date:  2015-02-04

9.  DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma.

Authors:  Brittany N Lasseigne; Todd C Burwell; Mohini A Patil; Devin M Absher; James D Brooks; Richard M Myers
Journal:  BMC Med       Date:  2014-12-04       Impact factor: 8.775

10.  Renal incidental findings on computed tomography: Frequency and distribution in a large non selected cohort.

Authors:  Hans Jonas Meyer; Alina Pfeil; Dominik Schramm; Andreas Gunter Bach; Alexey Surov
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.